Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Sanofi India Limited ( (IN:SANOFI) ) has provided an update.
Sanofi India Limited announced that the Gujarat High Court has allowed its writ petition for a refund claim of Rs. 83,74,925 for the year 2014. The court directed the company to submit necessary documents to the jurisdictional authority for a rebate claim on export. This decision does not have a material impact on the company’s financial, operational, or other activities.
More about Sanofi India Limited
Sanofi India Limited operates in the pharmaceutical industry, providing a range of healthcare solutions including prescription medicines and vaccines. The company focuses on improving patient health and has a significant presence in the Indian market.
YTD Price Performance: -4.20%
Average Trading Volume: 2,245
Current Market Cap: 131.9B INR
For detailed information about SANOFI stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “Next-Generation Brain-Computer Interface”: Microsoft Stock (NASDAQ:MSFT) Gains With New AI Possibilities
- “May Not Fit Squarely in Tesla’s Mission”: Tesla (NASDAQ:TSLA) Shareholders Pass on xAI Investment
- Uh-Oh: Starbucks Stock (NASDAQ:SBUX) Slips as it Discovers How Little the Coffeehouse Experience Matters